The World's First Blood Test to Detect Coronary Heart Disease

PrecisionCHD™ is Cardio Diagnostics’ second product that was developed using our AI-driven Integrated Genetic-Epigenetic Engine™ and was validated in collaboration with Intermountain Healthcare and University of Iowa Hospitals and Clinics.

PrecisionCHD™ is a powerful test that combines epigenetics, genetics and artificial intelligence to assess the presence of coronary heart disease (CHD), the most common type of heart disease and the major cause of heart attacks.

No radiation

Available for adults 35+ years old

No fasting

1

Test order (Rx only)

and blood draw via phlebotomy (provider settings) or finger stick (at-home)

2

Return of results to provider within 7-10 business days of receipt at the lab

3

Clinician reviews and shares insights tailored to each patient to help elucidate areas of concern

4

Personalized monitoring to improve patient outcomes

Eligibility Criteria:

The PrecisionCHD™ test is intended for adults:

• between the ages of 35-80
• presenting to be evaluated for CHD
• who have NOT had a bone marrow transplant

Order now and receive a test kit where you can collect your blood sample remotely via finger-prick, or talk to your doctor about how they can order PrecisionCHD.

Objective Biomarkers for

Personalized Cardiovascular Intelligence

PrecisionCHD™ Sample Results

Coupled with Actionable Clinical Intelligence™

PrecisionCHD™ comes with a one-of-a-kind platform (ACI™) that integrates the patient’s test results, their unique epigenetic and genetic biomarkers, and clinical information to provide deeper and actionable insights to clinicians about factors contributing to the patient’s coronary heart disease.

We believe shared decision-making in healthcare is essential for clinicians and their patients, and ACI makes this a reality.